European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

5 EU fundings (€530,454): Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 … BdlYear 2015 EU Research and Innovation programme "Horizon"

Text

Schweizer Handelsregister CHE-106.052.527

01/07/2015 EU funding (€1,130,000): Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890
01/11/2015 EU funding (€17.6M): Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797
01/01/2015 EU funding (€2,851,275): Design and development of advanced NAnomedicines to overcome Biological BArriers and to treat severe diseases
27/08/2015 EU funding (€3,836,996): Accelerated Early staGe drug diScovery
27/08/2015 EU funding (€3,842,482): FRAGments training NETwork

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Novartis Pharma AG, Basle, Switzerland.

Creative Commons License The visualizations for "5 EU fundings (€530,454): Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.